Clinical Trials Directory

Trials / Unknown

UnknownNCT03605381

MORbidity PRevalence Estimate In StrokE

Morbidity Prevalence Estimate at Six Months Following a Stroke: A Cohort Study.

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Aneurin Bevan University Health Board · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Information regarding the likely progress of post-stroke symptoms is vitally important to stroke survivors to allow them to plan for the future and to adjust to life after stroke. Moreover, the prevalence of morbidity secondary to stroke is of central importance to Health Professionals to understand the prognosis of the disease in the patients under their care. Additionally, it will also allow commissioners of care, planners and third sector organisations to adapt to and answer the needs of a post-stroke population. Currently, the data collected by national audit programmes are concentrated on what can be termed 'process or process of care' data. The utility of these data are in the ability to audit the care received by stroke survivors on stroke units against evidenced standards for care, thus ensuring evidence based practice. Nevertheless, process of care is only one form of measuring stroke unit care and the audit programmes collect some limited functional status data, data relating to risk-factor co-morbidities and treatment received data. Therefore, the scope of this study is to build on the minimum data set currently collected and to collect post-stroke data in domains not currently collected. The International Consortium for Health Outcomes Measurement (ICHOM) takes important steps to collect data outside of process of care data such as a Patient Reported outcome data in their minimum outcome data set for stroke \[currently under review\].. Nevertheless, the ICHOM doesn't currently advocate the specific collection of data relating to cognitive impairment or emotional problems secondary to stroke. It is in these important aspects that this study will augment the data set currently advocated by ICHOM to collect data in the areas of cognitive impairment and emotional problems secondary to stroke. Therefore, the aim of this study is to quantify the prevalence of morbidity at six months post-stroke.

Conditions

Timeline

Start date
2018-09-30
Primary completion
2019-08-31
Completion
2019-09-30
First posted
2018-07-30
Last updated
2019-07-05

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03605381. Inclusion in this directory is not an endorsement.